Regulations.gov document
Reference 3 - Guidance for FDA Reviewers and Sponsors: Content and Review of Chemistry…
Supporting & Related Material · FDA-2024-D-1244 · posted Apr 30, 2024
Key facts
| Document ID | FDA-2024-D-1244-0005 |
|---|---|
| Title | Reference 3 - Guidance for FDA Reviewers and Sponsors: Content and Review of Chemistry, Manufacturing, and Control (CMC) Information for Human Somatic Cell Therapy Investigational New Drug Applications (INDs), April 2008, https://www.fda.gov/media/73624/download. |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2024-D-1244 |
| Posted | Apr 30, 2024 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: